Alumnus Spotlight: Terry Kramer ’82 – Supporting UCLA

/in /by

UCLA Economics Alumnus, Terry Kramer ’82, and member of the Economics Department Board of Visitors is the subject of the most recent “Alumnus Spotlight.”   Terry was also the guest of honor and delivered the Commencement Address to our Economics class of 2025.

Read the full story here.

UCLA Professor Till von Wachter and the California Policy Lab awarded a $5.95M grant from Conrad N Hilton Foundation

/in /by

The Conrad N Hilton Foundation has awarded a $5.95 million grant to Professor Till von Wachter and the California Policy Lab (CPL). The foundation, a long-term supporter of the Lab, approved this landmark, three-year grant in recognition of CPL’s leadership and data-driven approach on strategies to prevent homelessness. The grant announcement can be found here: https://www.hiltonfoundation.org/news/advancing-homelessness-prevention-through-research-and-policy-a-conversation-with-janey-rountree-of-the-california-policy-lab/.

UCLA Professor Till von Wachter and the California Policy Lab win UCLA’s Public Impact Research Award

/in /by

UCLA Professor Till von Wachter and the California Policy Lab, a nonpartisan research institute at the University of California, receive UCLA’s Public Impact Research Award. The award recognizes faculty whose research produces meaningful public impact, especially when paired with sustained efforts to share new insights with the broader public. The award is presented annually by UCLA’s Office of Research and Creative Activities. The award announcement can be found here: https://capolicylab.org/news/california-policy-lab-wins-2025-public-impact-research-award-for-transformative-research/ .

The National Institute of Health Awards UCLA Professor Martha Bailey an R01 Grant

/in /by
Professor Martha Bailey received an R01 Grant from the National Institute of Health for her research project “The Effects of Contraceptive Access on Women’s Health and Wellbeing: Evidence from a Randomized Control Trial at Five Years.”
 
The project will conduct a follow-up study of an NIH-funded randomized control trial (RCT) that made contraception more affordable for U.S. women seeking care at Title X providers–a federal program that has offered subsidized, patient-centered reproductive health services since 1970. From 2018-23, the Michigan Contraceptive Access, Research, and Evaluation Study (M-CARES) randomly assigned vouchers making any method of contraception highly discounted or free and has followed participants for two years in administrative and survey data. The proposed project extends the scope of M-CARES to consider a comprehensive set of health and well-being outcomes measured three to five years after study enrollment. The project’s specific aims are to:
(1) Link M-CARES participants to administrative records three to five years after enrollment, including (a) birth records, (b) credit reports, (c) IRS tax and Census data, and (d) health care records to be used for research.
(2) Develop and field a year-five follow-up survey (Y5FU), which will focus on information missing or incomplete in administrative records, including (a) contraceptive use; (b) retrospective pregnancy outcomes and desire/intendedness; (c) physical and mental health; (d) relationship stability and quality; (e) education and labor-market outcomes; (f) financial stability; (g) parenting; and (h) overall well-being.
(3) Quantify the cumulative causal effects of reducing the costs of contraception on outcomes measured three to five years later, using the RCT’s random assignment and outcomes from data in Aims 1 and 2.
Achieving these aims contributes novel and rigorous evidence regarding how the affordability of contraception affects a comprehensive set of health and well-being outcomes at three to five years. The combination of administrative and survey data maximizes the information collected per dollar spent and minimizes attrition and measurement error. Achieving this study’s aims is highly relevant to understanding how public policy could mitigate the potential negative effects of Dobbs and for providing a more complete cost-benefit accounting of public programs subsidizing contraceptives, such as Title X and Medicaid.